This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Prognosis

Authoring team

If patients with a microprolactinoma respond to bromocriptine, in 25% of cases after a couple of years the bromocriptine can be stopped as the hyperprolactinaemia does not recur. (1)

Even when large invasive macroadenomas or giant prolactinomas are diagnosed with chiasmal compression and bilateral temporal hemianopia, continuous treatment with relatively large doses of dopamine agonists will result in prolactin normalisation, tumour shrinkage or disappearance, and rapid visual improvement. (2)

Reference

  1. Xia MY, Lou XH, Lin SJ, et al. Optimal timing of dopamine agonist withdrawal in patients with hyperprolactinemia: a systematic review and meta-analysis. Endocrine. 2018 Jan;59(1):50-61.
  2. Shimon I. Giant prolactinomas. Neuroendocrinology. 2019;109(1):51-6.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2026 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.